Skinvisible (SKVI) Accumulated Expenses (2010 - 2026)

Skinvisible has disclosed Accumulated Expenses across 17 years of filings, most recently posting $3.5 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $3.5 million, up 19.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 19.56% YoY), and the FY2025 annual result was $3.4 million, up 20.55% from the prior year.
• Accumulated Expenses came in at $3.5 million for Q1 2026 at Skinvisible, up from $3.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.5 million in Q1 2026 to a low of $1.6 million in Q1 2022.
• The 5-year median for Accumulated Expenses is $2.6 million (2024), against an average of $2.6 million.
• Across the five-year window, Accumulated Expenses soared 42.46% in 2022 and advanced 6.83% in 2025, its largest moves.
• Skinvisible's Accumulated Expenses stood at $2.0 million in 2022, then surged by 31.69% to $2.6 million in 2023, then climbed by 8.13% to $2.8 million in 2024, then grew by 20.55% to $3.4 million in 2025, then climbed by 4.21% to $3.5 million in 2026.
• The last three Accumulated Expenses figures came in at $3.5 million (Q1 2026), $3.4 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.